Welcome to Seeking Alpha's Wall Street Breakfast, where we cover the top news for investors every morning.

It's good to have you here on this Tuesday, February 17th. I'm Julie Morgan.

Massimo is up 32% in pre-market action. Danahur is nearing a roughly $10 billion deal to acquire the medical

technology firm. The Financial Times reported citing people familiar with the matter that a deal

could be announced as early as today, provided it does not hit any last-minute snags. The deal value

represents a premium to its nearly $7 billion market cap at Friday's close.

Massimo manufactures pulse oxymeters, which measures blood oxygen levels. The company has

challenged Apple over breaching its patents in a long-running intellectual property dispute

over the Apple Watch. The Massimo deal could be Danaher's biggest acquisition in more than half a decade.

Massimo's stock has declined by 27% over the past year.

Danaher is down 4% pre-market.

Activist investor Elliott Investment Management has bought over a 10% stake in Norwegian

cruise line holdings, positioning it as one of the company's largest shareholders. The Wall

Street Journal reported citing sources familiar with the matter that Elliott intends to advocate

for major operational and strategic changes to address underperformance.

The cruise company has fallen behind competitors, with its shares down nearly 4% year-to-date,

compared to gains of 4.5% for Carnival and 15% for Royal Caribbean.

Norwegian shares sank on week Q3 results and forecast amid worrying cruise industry trends. It's important to note that the company recently appointed a new

CEO, the former CEO of Subway and Burger King, as president and CEO effective February 12th of this year,

replacing Harry Summer.

Costco is reportedly facing a new lawsuit over its rotisserie chicken.

The proposed class action lawsuit filed on Thursday cited a December study from an animal rights

...